Exchange: NYSE·Updated 07:30 PM EST

BDX News

News
all
press releases
Becton, Dickinson and Company (NYSE:BDX) Rating Lowered to "Hold" at Zacks Research
Zacks Research downgraded shares of Becton, Dickinson and Company from a "strong-buy" rating to a "hold" rating in a research note on Thursday...
MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Rating Lowered to "Hold" at Zacks Research
Zacks Research downgraded shares of Becton, Dickinson and Company from a "strong-buy" rating to a "hold" rating in a research note on Thursday...
MarketBeat
More News
BD Marks 85 Years of Essential Medical Device Manufacturing in Glen Falls, NY BD Marks 85 Years of Essential Medical Device Manufacturing in Glen Falls, NYPR NewswireFRANKLIN LAKES, N.J., Nov. 19, 2026 Founded during World War II to fill a critical supply gap, the longest-running site in BD's...
PR Newswire
BD Named to TIME's 2027 List of America's Top Manufacturers BD Named to TIME's 2027 List of America's Top ManufacturersPR NewswireFRANKLIN LAKES, N.J., Nov. 19, 2026 Recognition underscores BD's longstanding U.S. manufacturing leadership and critical role strengthening America's healthcare...
PR Newswire
Boston Scientific's weak WATCHMAN demand, EP market share losses and lowered 2026 outlook raise concerns over its growth prospects. Is it time to exit?
Zacks
Shares of Becton, Dickinson and Company (NYSE:BDX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eighteen research firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have assigne...
MarketBeat
Aberdeen Group plc boosted its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 24.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 523,400 shares of the medical instruments supplier's stock after...
MarketBeat
BD to Host Investor Day on December 10, 2026 BD to Host Investor Day on December 10, 2026PR NewswireFRANKLIN LAKES, N.J., Nov. 10, 2026 FRANKLIN LAKES, N.J., Nov. 10, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced...
PR Newswire
DENTSPLY SIRONA's Q3 sales decline 7.6% amid dental weakness, while Wellspect growth provides support. The company lowers its 2026 outlook.
Zacks
BDX, COR and UNF recently hiked dividends, offering investors steady income opportunities as market volatility, inflation and economic uncertainty persist.
Zacks
BD stock lost 6.4% in pre-market trading despite Q4 earnings and revenue beat, as its subdued fiscal 2027 revenue growth outlook raises investor concerns.
Zacks

Advertisement|Remove ads.